July 21st, 2010
FDA Halts New Enrollment in TIDE
Larry Husten, PHD
The FDA has halted new enrollment in TIDE (Thiazolidinedione Intervention with Vitamin D Evaluation), the controversial Avandia safety study, by placing the study on “partial clinical hold.” Patients already enrolled in the trial will continue to participate. The FDA said in a statement that it had instructed GlaxoSmithKline to “update investigators, institutional review boards (IRBs) and ethics committees […]
July 21st, 2010
Thoughts from a First-Year Fellowship Survivor
Shane LaRue, MD
Incoming fellows: Surely you’ve already been inundated with advice. People have their little tidbits of wisdom that they think you must know as you start your fellowship. Some tidbits are true and useful; others — well, not so much. Unfortunately, it is not always obvious which is which. As one who has just finished his […]
July 20th, 2010
Avandia Panelist Received Money from GSK
Larry Husten, PHD
One of the voting members of last week’s controversial Avandia panel received speaking fees from GlaxoSmithKline, the manufacturer of Avandia, according to news reports in the Wall Street Journal and Pharmalot. The FDA had previously said that there were no relevant conflicts for any of the 33 voting members of the panel. David Capuzzi, an endocrinologist at […]
July 20th, 2010
Who Should Treat Advanced HF/Transplant Patients?
Larry Husten, PHD
The ACC, AHA, and several other organizations have released the first Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant. “The current statement describes the level of experience, knowledge, and technical skills necessary for competent performance in caring for these complex patients,” write the authors of the report, including the chair […]
July 20th, 2010
We’ve made some big changes…
Larry Husten, PHD
We’ve redesigned CardioExchange based on your participation and feedback! You’ll see a new look and feel, and functionality to make it easier to join the dialogue. New Ways to Connect with the CardioExchange Community The site includes two important new features to help you get the most out of your time on CardioExchange: The Recent […]
July 16th, 2010
FDA reviewing link between ARBs and cancer
Larry Husten, PHD
The FDA issued a safety communication and stated that it was conducting a review of ARBs and cancer.
July 15th, 2010
Heart Failure Society of America
CardioExchange Editors, Staff
Heart Failure Society of America 15th Annual Scientific Meeting Boston, MA
July 15th, 2010
Heart Failure Society of America
Larry Husten, PHD
Boston, MA 15th Annual Scientific Meeting
July 15th, 2010
43rd Annual New York Cardiovascular Symposium
Larry Husten, PHD
New York, NY Learning Pathway: General Cardiology: Hypertension, Lipids and Prevention, Program #: 1613
July 15th, 2010
How to Become a Cardiovascular Investigator
Larry Husten, PHD
Washington, DC Learning Pathway: General Cardiology: Hypertension, Lipids and Prevention, Program #: 1695